Tanke Biosciences Corporation (TNBI)
OTCMKTS · Delayed Price · Currency is USD
0.0235
-0.0185 (-44.05%)
At close: Jun 13, 2025
Tanke Biosciences Revenue
Tanke Biosciences had revenue of $6.04M in the quarter ending September 30, 2013, a decrease of -39.02%.
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
130
Market Cap
576.63K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2012 | 28.56M | 4.73M | 19.84% |
| Dec 31, 2011 | 23.83M | 3.73M | 18.58% |
| Dec 31, 2010 | 20.10M | 7.93M | 65.15% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Federal National Mortgage Association | 28.93B |
| Federal Home Loan Mortgage | 23.43B |
| First National of Nebraska | 1.89B |
| Mechanics Bank | 381.61M |
| Wilson Bank Holding Company | 189.72M |
| Copper Property CTL Pass Through Trust | 99.49M |
| QDM International | 8.38M |
| First National Bank Alaska | 199.84M |
Tanke Biosciences News
- 4 months ago - Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors - GlobeNewsWire